Skip to main content
Top
Published in: Metabolic Brain Disease 2/2010

01-06-2010 | Original Paper

Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes—a 1H MRS study

Authors: Outi Heikkilä, Nina Lundbom, Marjut Timonen, Per-Henrik Groop, Sami Heikkinen, Sari Mäkimattila

Published in: Metabolic Brain Disease | Issue 2/2010

Login to get access

Abstract

Acute hyperglycaemia impairs cognitive function. It is however not known, whether different brain regions are equally exposed to glucose during acute hyperglycemia or whether the brain is able to adjust its glucose uptake or metabolism in response to blood glucose fluctuation. We studied the effect of acute hyperglycaemia on the brain glucose concentration in seven men with type 1 diabetes with daily glucose fluctuations of 11 ± 3 mmol/l, and in eleven age-matched non-diabetic men. Glucose was quantified with proton magnetic resonance spectroscopy in three different brain regions at baseline (fasting glycaemia) and twice during a 2 h hyperglycaemic clamp with plasma glucose increase of 12 mmol/l. The increase in brain glucose during acute hyperglycaemia in the non-diabetic group was: cortex (2.7 ± 0.9 mmol/l) > thalamus (2.3 ± 0.7 mmol/l) > white matter (1.7 ± 0.7 mmol/l, P = 0.021 vs. cortex) and in the diabetic group: cortex (2.0 ± 0.7 mmol/l) > white matter (1.3 ± 0.7 mmol/l) > thalamus (1.1 ± 0.4 mmol/l, P = 0.010 vs. cortex). In the diabetic group, the glucose increase in the thalamus was attenuated compared to the non-diabetic participants (P = 0.011). In conclusion, the increase of glucose during acute hyperglycaemia seems to be dependent on the brain tissue type. The high exposure of cortex to excess glucose and the altered glucose uptake or metabolism in the thalamus may thus contribute to hyperglycaemia related cognitive dysfunction.
Literature
go back to reference Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J, Kerr D, Leone P, Krystal JH, Spencer DD, During MJ, Sherwin RS (2002) Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22:271–279CrossRefPubMed Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J, Kerr D, Leone P, Krystal JH, Spencer DD, During MJ, Sherwin RS (2002) Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22:271–279CrossRefPubMed
go back to reference Arbelaez AM, Powers WJ, Videen TO, Price JL, Cryer PE (2008) Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes 57:470–475CrossRefPubMed Arbelaez AM, Powers WJ, Videen TO, Price JL, Cryer PE (2008) Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes 57:470–475CrossRefPubMed
go back to reference Baslow MH (2003) N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28:941–953CrossRefPubMed Baslow MH (2003) N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28:941–953CrossRefPubMed
go back to reference Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, Marsden PK, Amiel SA (2005) Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia 48:2080–2089CrossRefPubMed Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, Marsden PK, Amiel SA (2005) Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia 48:2080–2089CrossRefPubMed
go back to reference Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ (1995) Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 333:1726–1731CrossRefPubMed Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ (1995) Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 333:1726–1731CrossRefPubMed
go back to reference Bragd J, Adamson U, Backlund LB, Lins PE, Moberg E, Oskarsson P (2008) Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diab Metab 34:612–616CrossRef Bragd J, Adamson U, Backlund LB, Lins PE, Moberg E, Oskarsson P (2008) Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diab Metab 34:612–616CrossRef
go back to reference Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diab Care 28:726–735CrossRef Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diab Care 28:726–735CrossRef
go back to reference Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER (2005) Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res 79:42–47CrossRefPubMed Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER (2005) Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res 79:42–47CrossRefPubMed
go back to reference Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL 3rd, Knatterud GL (1998) Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report #18. Invest Ophthalmol Vis Sci 39:233–252PubMed Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL 3rd, Knatterud GL (1998) Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report #18. Invest Ophthalmol Vis Sci 39:233–252PubMed
go back to reference de Graaf RA, Pan JW, Telang F, Lee JH, Brown P, Novotny EJ, Hetherington HP, Rothman DL (2001) Differentiation of glucose transport in human brain gray and white matter. J Cereb Blood Flow Metab 21:483–492CrossRefPubMed de Graaf RA, Pan JW, Telang F, Lee JH, Brown P, Novotny EJ, Hetherington HP, Rothman DL (2001) Differentiation of glucose transport in human brain gray and white matter. J Cereb Blood Flow Metab 21:483–492CrossRefPubMed
go back to reference Duelli R, Maurer MH, Staudt R, Heiland S, Duembgen L, Kuschinsky W (2000) Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res 858:338–347CrossRefPubMed Duelli R, Maurer MH, Staudt R, Heiland S, Duembgen L, Kuschinsky W (2000) Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res 858:338–347CrossRefPubMed
go back to reference Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Cryer PE, Powers WJ (1998) Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes 47:1444–1450CrossRefPubMed Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Cryer PE, Powers WJ (1998) Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes 47:1444–1450CrossRefPubMed
go back to reference Fricker G, Nobmann S, Miller DS (2002) Permeability of porcine blood brain barrier to somatostatin analogues. Br J Pharmacol 135:1308–1314CrossRefPubMed Fricker G, Nobmann S, Miller DS (2002) Permeability of porcine blood brain barrier to somatostatin analogues. Br J Pharmacol 135:1308–1314CrossRefPubMed
go back to reference Geurts JJ, Barkhof F, Castelijns JA, Uitdehaag BM, Polman CH, Pouwels PJ (2004) Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. J Magn Reson Imaging 20:366–371CrossRefPubMed Geurts JJ, Barkhof F, Castelijns JA, Uitdehaag BM, Polman CH, Pouwels PJ (2004) Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. J Magn Reson Imaging 20:366–371CrossRefPubMed
go back to reference Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU, Ritterband LM, Magee JC, Cox DJ, Clarke WL (2009) Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diabetes Care Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU, Ritterband LM, Magee JC, Cox DJ, Clarke WL (2009) Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diabetes Care
go back to reference Gross TM, Mastrototaro JJ (2000) Efficacy and reliability of the continuous glucose monitoring system. Diab Technol Ther 2(Suppl 1):S19–S26CrossRef Gross TM, Mastrototaro JJ (2000) Efficacy and reliability of the continuous glucose monitoring system. Diab Technol Ther 2(Suppl 1):S19–S26CrossRef
go back to reference Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2008) Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism. Metab Brain Dis 23:315–324CrossRefPubMed Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2008) Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism. Metab Brain Dis 23:315–324CrossRefPubMed
go back to reference Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2009) Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia 52:534–540CrossRefPubMed Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2009) Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia 52:534–540CrossRefPubMed
go back to reference Kreis R, Arcinue E, Ernst T, Shonk TK, Flores R, Ross BD (1996) Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J Clin Invest 97:1142–1154CrossRefPubMed Kreis R, Arcinue E, Ernst T, Shonk TK, Flores R, Ross BD (1996) Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J Clin Invest 97:1142–1154CrossRefPubMed
go back to reference Long JB, Rigamonti DD, Dosaka K, Kraimer JM, Martinez-Arizala A (1992) Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system. J Pharmacol Exp Ther 260:1425–1432PubMed Long JB, Rigamonti DD, Dosaka K, Kraimer JM, Martinez-Arizala A (1992) Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system. J Pharmacol Exp Ther 260:1425–1432PubMed
go back to reference Mason GF, Pan JW, Chu WJ, Newcomer BR, Zhang Y, Orr R, Hetherington HP (1999) Measurement of the tricarboxylic acid cycle rate in human grey and white matter in vivo by 1H-[13C] magnetic resonance spectroscopy at 4.1T. J Cereb Blood Flow Metab 19:1179–1188CrossRefPubMed Mason GF, Pan JW, Chu WJ, Newcomer BR, Zhang Y, Orr R, Hetherington HP (1999) Measurement of the tricarboxylic acid cycle rate in human grey and white matter in vivo by 1H-[13C] magnetic resonance spectroscopy at 4.1T. J Cereb Blood Flow Metab 19:1179–1188CrossRefPubMed
go back to reference McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB (1986) Chronic hypoglycemia increases brain glucose transport. Am J Physiol 251:E442–E447PubMed McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB (1986) Chronic hypoglycemia increases brain glucose transport. Am J Physiol 251:E442–E447PubMed
go back to reference McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565–573PubMed McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565–573PubMed
go back to reference Norton WT (1975) The nervous system in the basic neurosciences. Raven, New York Norton WT (1975) The nervous system in the basic neurosciences. Raven, New York
go back to reference Oizumi XS, Akisaki T, Kouta Y, Song XZ, Takata T, Kondoh T, Umetani K, Hirano M, Yamasaki K, Kohmura E, Yokono K, Sakurai T (2006) Impaired response of perforating arteries to hypercapnia in chronic hyperglycemia. Kobe J Med Sci 52:27–35PubMed Oizumi XS, Akisaki T, Kouta Y, Song XZ, Takata T, Kondoh T, Umetani K, Hirano M, Yamasaki K, Kohmura E, Yokono K, Sakurai T (2006) Impaired response of perforating arteries to hypercapnia in chronic hyperglycemia. Kobe J Med Sci 52:27–35PubMed
go back to reference Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371–388CrossRefPubMed Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371–388CrossRefPubMed
go back to reference Quirce R, Carril JM, Jimenez-Bonilla JF, Amado JA, Gutierrez-Mendiguchia C, Banzo I, Blanco I, Uriarte I, Montero A (1997) Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 24:1507–1513CrossRefPubMed Quirce R, Carril JM, Jimenez-Bonilla JF, Amado JA, Gutierrez-Mendiguchia C, Banzo I, Blanco I, Uriarte I, Montero A (1997) Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 24:1507–1513CrossRefPubMed
go back to reference Schlenk F, Nagel A, Graetz D, Sarrafzadeh AS (2008) Hyperglycemia and cerebral glucose in aneurysmal subarachnoid hemorrhage. Intensive Care Med 34:1200–1207CrossRefPubMed Schlenk F, Nagel A, Graetz D, Sarrafzadeh AS (2008) Hyperglycemia and cerebral glucose in aneurysmal subarachnoid hemorrhage. Intensive Care Med 34:1200–1207CrossRefPubMed
go back to reference Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13:387–414PubMed Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13:387–414PubMed
go back to reference Seaquist ER, Tkac I, Damberg G, Thomas W, Gruetter R (2005) Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 54:1008–1013CrossRefPubMed Seaquist ER, Tkac I, Damberg G, Thomas W, Gruetter R (2005) Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 54:1008–1013CrossRefPubMed
go back to reference Segel SA, Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Powers WJ, Cryer PE (2001) Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 50:1911–1917CrossRefPubMed Segel SA, Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Powers WJ, Cryer PE (2001) Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 50:1911–1917CrossRefPubMed
go back to reference Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ, Smith QR (1999) Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 72:238–247CrossRefPubMed Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ, Smith QR (1999) Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 72:238–247CrossRefPubMed
go back to reference The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
go back to reference Urrila AS, Hakkarainen A, Heikkinen S, Huhdankoski O, Kuusi T, Stenberg D, Häkkinen AM, Porkka-Heiskanen T, Lundbom N (2006) Preliminary findings of proton magnetic resonance spectroscopy in occipital cortex during sleep deprivation. Psychiatry Res 147:41–46CrossRefPubMed Urrila AS, Hakkarainen A, Heikkinen S, Huhdankoski O, Kuusi T, Stenberg D, Häkkinen AM, Porkka-Heiskanen T, Lundbom N (2006) Preliminary findings of proton magnetic resonance spectroscopy in occipital cortex during sleep deprivation. Psychiatry Res 147:41–46CrossRefPubMed
go back to reference van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: a systematic review. Diab Care 29:2539–2548CrossRef van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: a systematic review. Diab Care 29:2539–2548CrossRef
Metadata
Title
Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes—a 1H MRS study
Authors
Outi Heikkilä
Nina Lundbom
Marjut Timonen
Per-Henrik Groop
Sami Heikkinen
Sari Mäkimattila
Publication date
01-06-2010
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 2/2010
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-010-9199-5

Other articles of this Issue 2/2010

Metabolic Brain Disease 2/2010 Go to the issue